Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism

Journal of Affective Disorders

Volumn 123, Issue 1-3, 2010, Pages 308-311

  Yevtushenko, Olga O ^a,b   Oros, Mykhaylo M ^c   Reynolds, Gavin P ^b  

^a Res Inst Pharmacol Toxicol   (Ukraine)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Clinic Vodolij   (Ukraine)

Author keywords

5 HT transporter; 5 HT1A receptor; Panic disorder; Pharmacogenetics; Selective serotonin reuptake inhibitors

Indexed keywords

PAROXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG DOSE TITRATION; DRUG RESPONSE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HEREDITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PHARMACOGENETICS; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; ALLELES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PAROXETINE; PERSONALITY INVENTORY; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952323602     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.09.007     Document Type: Article

References (17)

1. Basu A., and Aitchison K.J. Pharmacogenetics: antidepressant drug response. Psychiatry 4 (2005) 30-34
2. Blaya C., Salum G.A., Lima M.S., Leistner-Segal S., and Manfro G.G. Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis. Behav. Brain Funct. 3 (2007) 41
3. Cook Jr. E.H., Courchesne R., Lord C., Cox N.J., Yan S., Lincoln A., Haas R., Courchesne E., and Leventhal B.L. Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry 2 (1997) 247-250
4. Czesak M., Lemonde S., Peterson E.A., Rogaeva A., and Albert P.R. Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J. Neurosci. 26 (2006) 1864-1871
5. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., and Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 (1996) 2621-2624
6. Katon W.J. Clinical practice. Panic disorder. N. Engl. J. Med. 354 (2006) 2360-2367
7. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., and Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 141-148
8. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., and Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23 (2003) 8788-2799
9. Lemonde S., Du L., Bakish D., Hrdina P., and Albert P.R. Association of the C(- 1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int. J. Neuropsychopharmacol. 7 (2004) 501-506
10. Maron E., and Shlik J. Serotonin function in panic disorder: important, but why?. Neuropsychopharmacology 31 (2006) 1-11
11. Nash J.R., Sargent P.A., Rabiner E.A., Hood S.D., Argyropoulos S.V., Potokar J.P., Grasby P.M., and Nutt D.J. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br. J. Psychiatry 193 (2008) 229-234
12. Perna G., Favaron E., Di Bella D., Bussi R., and Bellodi L. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology 30 (2005) 2230-2235
13. Reynolds G.P., Arranz B., Templeman L.A., Fertuzinhos S., and San L. Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am. J. Psychiatry 163 (2006) 1826-1829
14. Rothe C., Gutknecht L., Freitag C., Tauber R., Mössner R., Franke P., Fritze J., Wagner G., Peikert G., Wenda B., Sand P., Jacob C., Rietschel M., Nöthen M.M., Garritsen H., Fimmers R., Deckert J., and Lesch K.P. Association of a functional 1019C > G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol. 7 (2004) 189-192
15. Roy-Byrne P., Craske M., and Stein M. Panic disorder. Lancet 368 (2006) 1023-1032
16. Spindelegger C., Lanzenberger R., Wadsak W., Mien L.K., Stein P., Mitterhauser M., Moser U., Holik A., Pezawas L., Kletter K., and Kasper S. Influence of escitalopram treatment on 5-HT(1A) receptor binding in limbic regions in patients with anxiety disorders. Mol. Psychiatry (2008) Published Online: 25 Mar 2008. PMID: 18362913
17. Strobel A., Gutknecht L., Rothe C., Reif A., Mossner R., Zeng Y., Brocke B., and Lesch K.P. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J. Neural Transm. 110 (2003) 1445-1453